Pharmaceuticals 2012, 5(7), 719-726; doi:10.3390/ph5070719
Review

Association of Marijuana Use and Cyclic Vomiting Syndrome

,  and * email
Received: 11 May 2012; in revised form: 13 June 2012 / Accepted: 19 June 2012 / Published: 29 June 2012
(This article belongs to the Special Issue Medical Marijuana)
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract: Cannabis use has become one of the most commonly abused drugs in the world. It is estimated that each year 2.6 million individuals in the USA become new users and most are younger than 19 years of age. Reports describe marijuana use as high as 40–50% in male Cyclic Vomiting Syndrome patients. It is this interest in cannabis in the World, coupled with recognition of a cyclic vomiting illness associated with its chronic use that beckons a review of the most current articles, as well as a contribution from our own experiences in this area. The similarities we have demonstrated for both cannibinoid hyperemesis syndrome and cyclic vomiting make the case that cannibinoid hyperemesis syndrome is a subset of patients who have the diagnoses of cyclic vomiting syndrome and the role of marijuana should always be considered in the diagnosis of CVS, particularly in males.
Keywords: cyclic vomiting syndrome; marijuana; nausea; vomiting; cannabinoid hyperemesis syndrome
PDF Full-text Download PDF Full-Text [48 KB, uploaded 29 June 2012 09:41 CEST]

Export to BibTeX |
EndNote


MDPI and ACS Style

Pattathan, M.B.; Hejazi, R.A.; McCallum, R.W. Association of Marijuana Use and Cyclic Vomiting Syndrome. Pharmaceuticals 2012, 5, 719-726.

AMA Style

Pattathan MB, Hejazi RA, McCallum RW. Association of Marijuana Use and Cyclic Vomiting Syndrome. Pharmaceuticals. 2012; 5(7):719-726.

Chicago/Turabian Style

Pattathan, Mithun B.; Hejazi, Reza A.; McCallum, Richard W. 2012. "Association of Marijuana Use and Cyclic Vomiting Syndrome." Pharmaceuticals 5, no. 7: 719-726.

Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert